Monday, September 10, 2018

Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a highly disabling form of multiple sclerosis (MS).


from Reuters: Business News https://ift.tt/2CDx2m3

Related Posts:

  • LATEST BUSINESS NEWS"Taking scary decisions is critical", says James Dawson who junked his existing teas to start again. from BBC News - Business https://ift.tt/2FIwCci … Read More
  • LATEST BUSINESS NEWSLyft is the first ride-sharing company to go public but Uber is expected to follow soon. from BBC News - Business https://ift.tt/2JPH7jF … Read More
  • LATEST BUSINESS NEWSRecently retired Pat and John say their motor home travel plans are on hold because of Brexit. from BBC News - Business https://ift.tt/2YyAcP6 … Read More
  • LATEST BUSINESS NEWSSports Direct boss Mike Ashley is considering a £61m bid for Debenhams, but can he can save it? from BBC News - Business https://ift.tt/2CIiCPp … Read More
  • LATEST BUSINESS NEWSYianni Charalambous transforms cars for the rich and famous people searching for that extra shine. from BBC News - Business https://ift.tt/2HLg0Et … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner